,dataset_name,cell_type,cell_type_ontology_id,donor_id,sex,race,development_stage,count,percentage
0,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",T cell,CL:0000084,SG_HEL_H289,male,Indian,30-year-old human stage,11,0.6425233644859812
1,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",platelet,CL:0000233,SG_HEL_H289,male,Indian,30-year-old human stage,1,0.05841121495327102
2,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",B cell,CL:0000236,SG_HEL_H289,male,Indian,30-year-old human stage,2,0.11682242990654204
3,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",monocyte,CL:0000576,SG_HEL_H289,male,Indian,30-year-old human stage,14,0.8177570093457943
4,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",natural killer cell,CL:0000623,SG_HEL_H289,male,Indian,30-year-old human stage,1,0.05841121495327102
5,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD4-positive, alpha-beta T cell",CL:0000624,SG_HEL_H289,male,Indian,30-year-old human stage,50,2.9205607476635516
6,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta T cell",CL:0000625,SG_HEL_H289,male,Indian,30-year-old human stage,5,0.29205607476635514
7,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",mature B cell,CL:0000785,SG_HEL_H289,male,Indian,30-year-old human stage,6,0.35046728971962615
8,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",memory B cell,CL:0000787,SG_HEL_H289,male,Indian,30-year-old human stage,20,1.1682242990654206
9,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",naive B cell,CL:0000788,SG_HEL_H289,male,Indian,30-year-old human stage,20,1.1682242990654206
10,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta cytotoxic T cell",CL:0000794,SG_HEL_H289,male,Indian,30-year-old human stage,132,7.710280373831775
11,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",gamma-delta T cell,CL:0000798,SG_HEL_H289,male,Indian,30-year-old human stage,33,1.9275700934579438
12,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",regulatory T cell,CL:0000815,SG_HEL_H289,male,Indian,30-year-old human stage,29,1.6939252336448596
13,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","naive thymus-derived CD4-positive, alpha-beta T cell",CL:0000895,SG_HEL_H289,male,Indian,30-year-old human stage,187,10.922897196261683
14,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","naive thymus-derived CD8-positive, alpha-beta T cell",CL:0000900,SG_HEL_H289,male,Indian,30-year-old human stage,183,10.689252336448599
15,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","central memory CD4-positive, alpha-beta T cell",CL:0000904,SG_HEL_H289,male,Indian,30-year-old human stage,179,10.455607476635514
16,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","effector memory CD4-positive, alpha-beta T cell",CL:0000905,SG_HEL_H289,male,Indian,30-year-old human stage,64,3.7383177570093453
17,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta memory T cell",CL:0000909,SG_HEL_H289,male,Indian,30-year-old human stage,94,5.490654205607477
18,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD4-positive, alpha-beta cytotoxic T cell",CL:0000934,SG_HEL_H289,male,Indian,30-year-old human stage,7,0.40887850467289716
19,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD16-negative, CD56-bright natural killer cell, human",CL:0000938,SG_HEL_H289,male,Indian,30-year-old human stage,4,0.23364485981308408
20,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD16-positive, CD56-dim natural killer cell, human",CL:0000939,SG_HEL_H289,male,Indian,30-year-old human stage,64,3.7383177570093453
21,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",mucosal invariant T cell,CL:0000940,SG_HEL_H289,male,Indian,30-year-old human stage,60,3.5046728971962615
22,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",CD14-positive monocyte,CL:0001054,SG_HEL_H289,male,Indian,30-year-old human stage,427,24.94158878504673
23,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD14-low, CD16-positive monocyte",CL:0002396,SG_HEL_H289,male,Indian,30-year-old human stage,107,6.25
24,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",CD1c-positive myeloid dendritic cell,CL:0002399,SG_HEL_H289,male,Indian,30-year-old human stage,11,0.6425233644859812
25,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",double negative T regulatory cell,CL:0011024,SG_HEL_H289,male,Indian,30-year-old human stage,1,0.05841121495327102
